← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN SUCCINATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2025-11-06
Drug application
- FDA Application #
ANDA213518- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN SUCCINATE
- Generic name
- SUMATRIPTAN SUCCINATE
- Active ingredients
- SUMATRIPTAN SUCCINATE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- Manufacturer
- Alembic Pharmaceuticals Inc.
- First approval
- 2025-11-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown